Christopher Andriano, DO
Interventional Pain Medicine · Stockbridge, GANPI 1922549351
Payments from drug & device makers
What this record shows
This record is dominated by grants: $25,000 of the $40,743 with a category attached, or 61.4%. 22 manufacturers reported payments, led by Medtronic at 41.5% of the total. Reporting peaked in 2022 at $26,941 and has fallen 95.2% since, to $1,287 in 2025. Among interventional pain medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $261.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$17K
- Boston Scientific$13K
- Abbott$8K
- Nevro Corp.$456
- SPR Therapeutics, Inc$224
- Curonix LLC$211
- plus $1K from 16 others
What the payments were for
- Grants$25,00061%
- Travel & lodging$9,08722%
- Food & beverage$6,51816%
- Education$1380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 22 | $16,913 |
| Boston Scientific | 28 | $13,411 |
| Abbott | 58 | $8,267 |
| Nevro Corp. | 6 | $456 |
| SPR Therapeutics, Inc | 2 | $224 |
| Curonix LLC | 3 | $211 |
| Collegium Pharmaceutical, Inc. | 10 | $189 |
| Biotronik NRO, Inc. | 4 | $185 |
| Spinal Simplicity, LLC | 5 | $157 |
| Nalu Medical, Inc. | 2 | $142 |
| GRT US Holding, Inc. | 1 | $114 |
| Relievant Medsystems, Inc. | 1 | $104 |
| Avanos Medical | 2 | $95 |
| Foundation Fusion Solutions, LLC | 3 | $60 |
| Vertex | 2 | $45 |
| Vertos Medical, Inc. | 1 | $42 |
| Globus Medical | 1 | $29 |
| Averitas Pharma Inc. | 1 | $26 |
| Bard Access Systems, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| AbbVie | 1 | $17 |
| Valinor Pharma, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$15,000
- WaveWriter Alpha Prime 16$10,139
- PROCLAIM$6,817
- GENERAL - THERAPIES$893
- Superion Indirect Decompression System$874
- VANTA ADAPTIVESTIM$698
- INTELLIS ADAPTIVESTIM$406
- ETERNA$323
- Omnia$253
- SPRINT PNS System$224
- Intracept$207
- Senza Spinal Cord Stimulation System$144
- INTELLIS$140
- Prospera$136
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$125
- Qutenza$114
- Nalu Neurostimulation System$106
How this compares
$40,743 in reported general payments places this provider in the 90th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 67 | $38,004 |
| Buprenorphine | 120 | $27,798 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 458 | $11,964 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 458 | $7,857 |
| Lidocaine | 74 | $6,700 |
| Gabapentin | 454 | $4,898 |
| Xtampza ErOxycodone Myristate | 12 | $4,457 |
| Pregabalin | 230 | $4,016 |
| Tramadol Hcl ErTramadol Hcl | 68 | $3,633 |
| Diclofenac Sodium | 65 | $3,608 |
| Tizanidine Hcl | 235 | $3,091 |
| Methocarbamol | 203 | $2,345 |
| Naloxone Hcl | 33 | $2,211 |
| Duloxetine Hcl | 156 | $1,335 |
| Cyclobenzaprine Hcl | 204 | $1,168 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $189 | $42,46179 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 129 interventional pain medicine providers in Georgia.
Other interventional pain medicine in Stockbridge
- Emmanuel GageBrunswick$602K
- Jordan TateJasper$540K
- Christopher BovinetBrunswick$338K
- David RosenfeldCovington$249K
- Nathan NeufeldNewnan$171K
- Ryan BudwanyLawrenceville$123K
- Alexandra MoreiraAtlanta$79K
- Sushanth BodaNewnan$55K
- Guensley DelvaWaycross$37K
- Richard EpterAugusta$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.